CYP1A1*2A polymorphism as a prognostic factor for the advanced lung cancer patients treated with EGFR-TKI and its correlation with EGFR mutation.
Q. Nie
No relevant relationships to disclose
S. An
No relevant relationships to disclose
X. Yang
No relevant relationships to disclose
W. Zhong
No relevant relationships to disclose
R. Liao
No relevant relationships to disclose
J. Yang
No relevant relationships to disclose
X. Zhang
No relevant relationships to disclose
Z. Chen
No relevant relationships to disclose
J. Su
No relevant relationships to disclose
Z. Xie
No relevant relationships to disclose
Y. Huang
No relevant relationships to disclose
Y. L. Wu
No relevant relationships to disclose